top of page
Theranos 2.0? Why the Ghost of Holmes Still Haunts Health Tech
In the aftermath of one of Silicon Valley’s most infamous frauds, the biotech sector finds itself confronting an uncomfortable echo....
Rich Washburn
Jun 4, 20253 min read
bottom of page